Previous Article | Next Article 
Molecular and Cellular Biology, March 2000, p. 1639-1648, Vol. 20, No. 5
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Two Novel Drosophila TAFIIs Have Homology
with Human TAFII30 and Are Differentially Regulated
during Development
Sofia
Georgieva,1,2,3
Doris
B.
Kirschner,1
Tereza
Jagla,4
Elena
Nabirochkina,2,3
Susanne
Hanke,5
Heide
Schenkel,5
Cécilia
de Lorenzo,5
Pradip
Sinha,6
Krysztof
Jagla,4
Bernard
Mechler,5 and
Làszlò
Tora1,*
Institut de Génétique et de
Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, F-67404
Illkirch Cedex, CU de Strasbourg,1 and
INSERM U.384, 63001 Clermont Ferrand
Cedex,4 France; Institute of Gene
Biology, Russian Academy of Sciences,2 and
University of Oslo, Center of Medical
Studies,3 Moscow, Russia; Department of
Development Genetics, Deutsches Krebsforschungszentrum, D-69120
Heidelberg, Germany5; and Drosophila
Stock Center, School of Life Sciences, Devi Ahilya, Vishwavidyala,
Vigyan Bhawan, Indore 452-001, India6
Received 26 July 1999/Returned for modification 31 August
1999/Accepted 18 November 1999
 |
ABSTRACT |
TFIID is a multiprotein complex composed of the TATA binding
protein (TBP) and TBP-associated factors (TAFIIs). The
binding of TFIID to the promoter is the first step of RNA polymerase II preinitiation complex assembly on protein-coding genes. Yeast (y) and
human (h) TFIID complexes contain 10 to 13 TAFIIs.
Biochemical studies suggested that the Drosophila (d) TFIID
complexes contain only eight TAFIIs, leaving a number of
yeast and human TAFIIs (e.g., hTAFII55,
hTAFII30, and hTAFII18) without known
Drosophila homologues. We demonstrate that
Drosophila has not one but two hTAFII30
homologues, dTAFII16 and dTAFII24, which are
encoded by two adjacent genes. These two genes are localized in a
head-to-head orientation, and their 5' extremities overlap. We show
that these novel dTAFIIs are expressed and that they are
both associated with TBP and other bona fide dTAFIIs in
dTFIID complexes. dTAFII24, but not dTAFII16,
was also found to be associated with the histone acetyltransferase
(HAT) dGCN5. Thus, dTAFII16 and dTAFII24 are functional homologues of hTAFII30, and this is the first
demonstration that a TAFII-GCN5-HAT complex exists in
Drosophila. The two dTAFIIs are differentially
expressed during embryogenesis and can be detected in both nuclei and
cytoplasm of the cells. These results together indicate that
dTAFII16 and dTAFII24 may have similar but not
identical functions.
 |
INTRODUCTION |
Initiation of transcription of
protein-encoding genes by RNA polymerase II requires transcription
factor TFIID, which is comprised of the TATA-binding protein (TBP) and
10 to 12 TBP-associated factors (TAFIIs) (2, 40,
42). TFIID directs preinitiation complex assembly on both
TATA-containing and TATA-less promoters. To date, most of the TFIID
components from Saccharomyces cerevisiae and humans have
been identified, partially characterized, and shown to be well
conserved during evolution (2, 25, 42). However, despite
intensive biochemical analysis and genetic studies of Drosophila
melanogaster TFIID (dTFIID) (8, 22, 43, 47) several
human and yeast TAFIIs have no known Drosophila homologues.
The different TAFII compositions of the distinct TFIID
complexes appear to play key roles in the functional specificity of these complexes. A series of TAFIIs, designated core
TAFIIs, may be present in all TFIID complexes, whereas
other TAFIIs are only found in defined TFIID
subpopulations, often detected in substoichiometric amounts compared to
TBP and core TAFIIs (2-4, 6, 9, 15, 17).
Recently, a novel human multiprotein complex has been characterized which contains neither TBP nor TBP-like factor but is composed of
several TAFIIs and a number of other polypeptides (5,
45). This complex, called TBP-free TAFII-containing
complex (TFTC), contains the GCN5 histone acetyltransferase (HAT)
activity, is able to direct preinitiation complex formation and
initiation of transcription in in vitro transcription assays, and can
mediate transcriptional activation by GAL-VP16 (5, 45).
Following the discovery of the TFTC, TAFIIs have also been
identified in different other HAT complexes, such as
TAFII90, TAFII68/61, TAFII60,
TAFII25, and TAFII20/17 in the yeast
SPT-ADA-GCN5 acetyltransferase (SAGA) complex (13),
TAFII31, TAFII30, and TAFII20/15 in
the human PCAF/GCN5 complex (30), and TAFII31 in
the human SPT3-TAFII31-GCN5 acetyltransferase (STAGA)
complex (26). The finding that coactivators of transcription
contribute to HAT activity further strengthens the idea that histone
acetylation and deacetylation can regulate gene activation (24,
46). Recent analyses have particularly shown that GCN5 not only
displays a HAT activity but also is required for correct expression of
various genes in yeast by catalyzing promoter-specific histone
acetylation (7, 48) and chromatin remodelling
(14). All TBP-free TAFII-HAT complexes,
including SAGA, TFTC, PCAF/GCN5, and STAGA, contain a HAT belonging to
the GCN5 family and can acetylate histone H3 in mononucleosomes
(5, 13, 26, 30, 45). These data suggest that
TAFII-GCN5-HAT complexes form transcriptional adapters able
to interact with chromatin templates and to potentiate transcriptional
activation. Differences in the polypeptide composition of the different
TBP-free TAFII-HAT complexes (5) suggest that
like TFIID, different subpopulations of TAFII-GCN5-HAT
complexes may exist in the cell and may confer a broad range of
regulatory capabilities in polymerase II transcription.
Human TAFII30 (hTAFII30) is present in about
50% of the hTFIID complexes (17). hTAFII30
interacts in vitro with activation function 2-containing region E of
the human estrogen receptor (17). Moreover, not only are
hTAFII30 and its yeast homologue yTAFII25
(21, 35) present in TFIID but also they were detected in all
of the TBP-free TAFII-GCN5-HAT complexes (13, 26, 30, 45). Surprisingly, in spite of the fact that a functional
homologue of human TAFII30 in yeast has been identified
(21), to date no hTAFII30 homologue in
Drosophila has yet been described (20). Moreover,
previous biochemical studies suggested that the Drosophila TFIID complex contains only eight TAFIIs, including
TAFII230, TAFII150, TAFII110,
TAFII80, TAFII60, TAFII40,
TAFII30
, and TAFII30
(8, 22, 43,
47), whereas human and yeast TFIIDs contain 10 to 12 subunits
(2, 42). In this report we demonstrate the existence of two
hTAFII30/yTAFII25 homologues in
Drosophila, designated dTAFII16 and
dTAFII24. These two dTAFIIs are encoded by two
partially overlapping genes whose transcription is oriented in opposite
directions. Furthermore we present evidence that both novel
dTAFIIs are bona fide TAFIIs and that they are
differentially expressed during Drosophila embryogenesis.
 |
MATERIALS AND METHODS |
Poly(A)+ RNA preparation and cDNA library
screening.
Preparation of poly(A)+ RNA from 0- to 9-h
and 0- to 16-h embryos, the construction of cDNA libraries, and the
screening of the cDNA libraries have been described (16,
44).
Immunization and antibody production.
To generate
anti-dTAFII16 and anti-dTAFII24 polyclonal
antibodies (PAbs), peptides (see Fig. 2) were synthesized, coupled to
ovalbumin as a carrier protein, and used for immunization of rabbits.
Rabbit sera were collected and purified on a SulfoLink column (Pierce),
to which the synthesized peptides had been previously conjugated
through the terminal cysteine of each peptide, according to
manufacturer's instructions. Antibodies against GCN5 (38), dTBP, and dTAFIIs (10, 22, 23) were previously described.
IP and Western blot analysis.
Routinely, 100 to 500 µl
(approximately 500 µg) of the indicated protein fractions was
immunoprecipitated with 50 µl of protein A-Sepharose (Pharmacia) and
approximately 2 µg of the different antibodies (as indicated in the
figures). Antibody-protein A-Sepharose-bound protein complexes were
washed three times with immunoprecipitation (IP) buffer (25 mM Tris-HCl
[pH 7.9], 10% [vol/vol] glycerol, 0.1% NP-40, 0.5 mM
dithiothreitol, 5 mM MgCl2) containing 0.5 M KCl and twice
with IP buffer containing 100 mM KCl. After the washing, 5 to 10 µl
of beads was boiled in sodium dodecyl sulfate (SDS) sample buffer and
protein was analyzed by SDS-polyacrylamide gel electrophoresis (PAGE).
Proteins were transferred to nitrocellulose membrane and probed with
primary antibodies. The purified anti-dTAFII16 and
anti-dTAFII24 antibodies were diluted 1,000-fold, the PAbs raised against dTAFII230, dTAFII110,
dTAFII80, and dTAFII40 were diluted 3,000-fold,
and the anti-dTBP antibodies were diluted 2,000-fold.
Peroxidase-conjugated goat anti-rabbit immunoglobulin (heavy plus light
chain) specific antibodies (Jackson ImmunoResearch Laboratories, Inc.)
were used as secondary antibodies. Detection by an ECL kit (Amersham)
was performed using standard methods.
Whole-mount in situ hybridization.
Wild-type Oregon R
embryos in different developmental stages were prepared and fixed as
previously described (44). Digoxigenin-labeled RNA probes
were synthesized in vitro by using dTAFII16 and
dTAFII24 cDNAs inserted in BlueScript SK(+) vector
(Stratagene Corp., La Jolla, Calif.) and T3 or T7 RNA polymerase.
Before hybridization, the RNA probes were reduced in size by mild
alkaline hydrolysis.
Immunochemistry.
Embryos were dechorionated in 3% bleach
(Roth GMbH, Karlsruhe, Germany) and washed extensively in 0.1% Triton
X-100 followed by deionized H2O. Fixation was performed by
shaking the embryos in 4% paraformaldehyde in phosphate-buffered
saline (PBS) buffer with an equal volume of heptane. The embryos were
then devitellinized by vigorous shaking in 1:1 heptane-0.1% sodium
deoxycholate, 0.1% Triton X-100, and 4% paraformaldehyde in PBS
buffer, washed in PBS, treated with methanol for 60 s, and
rehydrated in PBS containing 0.1% Tween and 0.1% Triton X-100 (PBTT).
The embryos were blocked for 1 h at room temperature in PBTT
containing 5% normal goat serum and 1% bovine serum albumin.
Anti-TAFII16 and anti-TAFII24 antibodies were
diluted 1:100 in the blocking solution and incubated with the embryos
overnight at 4°C in a humidified chamber. After three washes in PBTT,
the embryos were incubated for 60 min at room temperature with
anti-rabbit Cy3 secondary antibodies diluted 1:400 in PBTT. The embryos
were washed with PBS, treated for 90 min at room temperature with 0.4 mg of RNase A per ml in PBS, washed with PBS at room temperature with 5 mg of propidium iodide per ml, washed extensively with PBS, mounted in
Vectashield embedding medium (Vector Laboratories, Burlingame, Calif.),
and examined under a Zeiss confocal laser scanning microscope (Carl
Zeiss Jena GmbH, Jena, Germany).
Immunostaining of polytene chromosomes was performed as described
previously (33, 39) except that the anti-dTAFII
antibodies were diluted 100-fold.
Nucleotide sequence accession numbers.
The accession numbers
for the dTAFII16 and dTAFII24 cDNAs are
AJ243837 and AJ243836, respectively.
 |
RESULTS |
Identification of two Drosophila genes encoding novel
dTAFIIs.
As a result of the isolation and nucleotide
sequencing of the congested-like tracheae (colt)
locus from Drosophila (16), we noticed that the
genomic sequence located downstream from colt contained
transcribed sequences whose products may correspond to two proteins
displaying similarity to human TAFII30. To identify the
putative dTAFII transcripts, the nucleotide
sequences of previously isolated cDNA clones from the colt
locus were determined and aligned with the genomic DNA sequence. As
shown in Fig. 1, sequence analysis allowed us to classify these transcripts into four groups: (i) 10 cDNA
clones originating from the colt gene, (ii) 2 cDNA clones which correspond to the dTAFII gene adjacent to
colt and whose 3' extremities partially overlap with the 3'
extremity of the colt transcript, (iii) 3 cDNAs representing
a more distal dTAFII gene, and (iv) 9 cDNA
clones representing a fourth gene that encodes a novel protein with a
high content of hydrophobic amino acids. Comparison of the full-length
cDNA sequences corresponding to both dTAFII
genes showed that while the 3' halves of both
dTAFII coding sequences were relatively well
conserved, their 5' halves showed essentially no homology. Alignment of
the two classes of dTAFII cDNA with the genomic
DNA sequences revealed that they were synthesized from opposite
strands, that the 5' ends of both genes overlapped with each other, and
that each dTAFII transcript was made of two
exons (Fig. 1 and 2). Interestingly, the
colt locus (second chromosome, 23A region) contains an
unusually high number of genes. Transcripts from three of these genes
partially overlap: the transcripts of both
dTAFII genes overlap at their 5' halves, and the
3' extremity of the colt transcript has a 17-nucleotide overlap with the 3' end of the adjacent dTAFII
gene (Fig. 1).

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Map of the colt locus of D. melanogaster with the novel dTAFII16 and
dTAFII24 genes. Localization of the two
dTAFII genes together with an unknown gene
encoding a novel protein (with a high content of hydrophobic amino
acids) identified in the immediate vicinity of the colt gene
are shown. The coding sequences of the different transcripts are
indicated by solid boxes, and the noncoding transcribed regions are
indicated by open boxes. The exon organization and the 5' and 3'
orientation of the transcripts were determined from sequence analysis
of cDNAs and from their alignment with the genomic DNA.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 2.
Nucleotide and amino acid sequences of the two novel
dTAFIIs. (A) The dTAFII16 ORF extends from
nucleotide 272 to 719. (B) The dTAFII24 ORF extends from
nucleotide 61 to 562. Both transcripts were aligned with the genomic
sequences, and the insertion points of the intronic sequences are
indicated with an arrowhead. The peptide sequences which were used to
generate PAbs are underlined in both amino acid sequences. (Accession
numbers of the dTAFII16 and dTAFII24 cDNAs are
AJ243837 and AJ243836, respectively.)
|
|
TAFII30 homologues from various species contain a
highly conserved C-terminal domain.
The two Drosophila
TAFII proteins were named according to their apparent
molecular weights in SDS-PAGE (see below). The more distal
dTAFII gene in relation to the colt
gene was designated dTAFII16, whereas the gene
adjacent to colt was called dTAFII24 (Fig. 1 and 2). The dTAFII16 transcript contains
an open reading frame (ORF) encoding a protein of 146 amino acids (Fig.
2A) with a molecular mass of 16,060 Da, which is in good agreement with its apparent molecular mass (see Fig. 4). The
dTAFII24 transcript contains an ORF producing a
protein of 167 amino acids (Fig. 2B) with a predicted molecular mass of
18,370 Da. However, the protein encoded by this gene migrates with an
apparent molecular mass of ~24 kDa (see Fig. 4). This is not
unprecedented among the human and yeast homologues of
dTAFII24, which all migrate at higher masses in SDS-PAGE
than their predicted molecular masses (17, 21). The
sequences of dTAFII16 and dTAFII24 proteins
were then used as query sequences in searches of different databases to find homologues. The result of this analysis confirmed that the two
novel dTAFIIs are indeed homologous to each other and to
human TAFII30 as originally hypothesized, but it also
revealed the presence of several homologues in different species,
including S. cerevisiae, Schizosaccharomyces
pombe, Arabidopsis thaliana, Caenorhabditis elegans, and Onchocerca volvulus. This comparison
indicated that both dTAFII16 and dTAFII24
proteins are members of the TAFII30 family of proteins with
an evolutionarily well conserved C-terminal domain (Fig.
3) and a divergent N-terminal moiety
(data not shown). The C-terminal domains of dTAFII16 and
dTAFII24 are 75% similar to each other and 77 and 75%
similar to the core domain of hTAFII30, respectively (Fig.
3 and data not shown).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 3.
Both novel dTAFIIs, dTAFII16 and
dTAFII24, are evolutionarily well conserved
TAFIIs containing a highly conserved C-terminal region.
TAFII coding sequences from various species were aligned
using the ClustalX program (18). The one-letter amino acid
code is used. TAFII sequences and their accession numbers
are as follows: TAFII30, U13991; mouse (mm)
TAFII30, AJ249987; S. cerevisiae (sc)
TAFII25, Q12030; S. pombe (sp)
TAFII25, spt:O60171; A. thaliana (at)
TAFII15, spt:O04173; C. elegans (ce)
TAFII30, spt:Q21172; O. volvulus (ov)
TAFII30, GB_NEW:AI111274. The presence of three or more
identical amino acids in all factors is indicated by a black
background. Note that when at certain positions there are equal numbers
(three or four) of two different amino acids they are not boxed by the
program.
|
|
dTAFII16 and dTAFII24 are both associated
with TFIID, whereas dTAFII24 is also associated with the
dGCN5 HAT.
To identify the proteins encoded by the two
dTAFII transcripts, rabbit PAbs were raised
against unique peptides derived from each of the dTAFIIs
(Fig. 2) (see Materials and Methods). Western blots of nuclear proteins
(NE) extracted from 0- to 6-h embryos (TRAX and SNF) (19,
34), cytoplasmic proteins from embryos (1), or total
proteins from Drosophila Schneider cells were probed with
either anti-dTAFII16 or anti-dTAFII24 PAbs
(Fig. 4A). The anti-dTAFII16
PAb specifically recognized a polypeptide having an apparent molecular
mass of about 16 kDa, and the anti-dTAFII24 PAb
specifically recognized a protein species migrating around 24 kDa (Fig.
4A). These results demonstrate that the newly identified dTAFIIs are expressed during early Drosophila
embryogenesis and in Schneider cells, indicating that the isolated
cDNAs encode the predicted protein sequences (Fig. 4A). Note that both
purified polyclonal sera cross-reacted with polypeptides other than the dTAFIIs on the Western blots, but these proteins were also
recognized by the corresponding preimmune sera (Fig. 4A, and data not
shown). Interestingly, dTAFII16 and dTAFII24
have been detected in both nuclear and cytoplasmic extracts (Fig. 4A,
lane 1 and 4). Furthermore, dTAFII16 was detected only in
the TRAX-type NE, not in the SNF-type NE (19, 34) (Fig. 4A,
lower panel). As the TRAX-type NE is prepared by using a more stringent
extraction procedure (34), this suggests that
dTAFII16 may be more tightly associated with the chromatin
than dTAFII24.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
dTAFII16 and dTAFII24 are bona
fide TAFIIs. (A) Proteins extracted from either
Drosophila embryos or Schneider cells were resolved by
SDS-PAGE and transferred onto a membrane. The blots were probed with
affinity-purified anti-dTAFII16 antibodies (lower panel) or
anti-dTAFII24 antibodies (upper panel).
Drosophila embryo NE were prepared according to the
procedures of either Kamakaka et al. (19) (SNF) or
Sandaltzopoulos and Becker (34) (TRAX). Whole cell extract
(WE) was prepared from Drosophila Schneider cells (Sch).
Cytoplasmic extract (CE) was prepared according to Becker and Wu
(1). Molecular mass markers (M) are indicated in
kilodaltons. (B) TBP and several bona fide dTAFIIs
coimmunoprecipitate with both dTAFII16 and
dTAFII24, whereas dGCN5 coimmunoprecipitates only with
dTAFII24. TRAX nuclear extract was immunoprecipitated with
anti-dTAFII16 ( -dTAFII16),
anti-dTAFII24 ( -dTAFII24), and anti-dTBP
( -dTBP) antibodies, as indicated. The input TRAX nuclear fraction
(Input), the supernatant of the immunoprecipitations (SN), and the
immunoprecipitated protein A-Sepharose-antibody bound proteins (IP)
were resolved on a 10% (upper panels) and a 15% (two lower panels)
SDS-polyacrylamide gel and transferred. The blots were then probed with
antibodies raised against dTAFII230, dTAFII110,
GCN5, dTAFII80, dTBP, dTAFII40,
dTAFII24, and dTAFII16, respectively.
|
|
To determine whether the newly identified dTAF
IIs are
indeed bona fide TBP-associated factors, we investigated whether
dTAF
II16
and dTAF
II24 are associated with dTBP
in the different immunopurified
TBP-containing complexes. To this end
we have carried out an IP
experiment using an anti-dTBP PAb
(
22). The anti-TBP IP depleted
all the dTAF
II24
and about 50% of dTAF
II16 from the input TRAX
NE (Fig.
4B,
compare lane 1 with 4), and both dTAF
II24 and
dTAF
II16
were found to be associated with TBP (lane 7).
Note that other
bona fide dTAF
IIs, such as
dTAF
II230, dTAF
II110, dTAF
II80, and
dTAF
II40, were also coimmunoprecipitated with dTBP (lane
7). When
the purified antisera raised against either
dTAF
II24 or dTAF
II16
were used as antibodies in
the IP experiments, both antibodies
coimmunoprecipitated dTBP as well
as dTAF
II230, dTAF
II110, dTAF
II80,
and dTAF
II40 from the TRAX NE (Fig.
4, lanes 5 and 6). In
contrast,
in the control IP using only protein A-Sepharose, no TBP or
dTAF
IIs
were detected (Fig.
4, lane 8). These results
demonstrate unequivocally
that the two newly identified
dTAF
IIs are associated with dTBP
in dTFIID
complexes.
Since the human and the yeast homologues of the two novel
dTAF
IIs have also been found in several TBP-free
TAF
II-GCN5-HAT-containing
complexes (
2), we
tested whether the antisera raised against
either dTAF
II16
or dTAF
II24 would also coimmunoprecipitate the
Drosophila GCN5 HAT (
38). Thus, we analyzed the
protein complexes
which were immunoprecipitated with either the
anti-dTAF
II16 or
the anti-dTAF
II24 PAb, as well
as with the anti-dTBP PAb as a
negative control, for the presence of
dGCN5 by Western blot analysis
using an anti-hGCN5 antibody that
cross-reacts with the
Drosophila protein (
38).
Interestingly, we found that the anti-dTAF
II24
PAb, but
neither the anti-dTAF
II16 PAb nor the anti-dTBP PAb,
coimmunoprecipitated dGCN5 (Fig.
4B, compare lane 6 with lanes
5 and
7), indicating that dTAF
II24 is present in a novel
Drosophila TAF
II-GCN5-HAT complex as well as in
dTFIID. These data also provide
the first demonstration that a
TAF
II-GCN5-HAT complex exists in
Drosophila.
dTAFII16 and dTAFII24 do not always target
the same set of genes.
If transcriptional selectivity can be
achieved at the level of distinct TAFII-containing
multiprotein complexes, then the different TAFII30 family
members (dTAFII16 and dTAFII24) might be
expected to be associated with different loci of the genome. Immunostainings of Drosophila salivary gland polytene
chromosomes show that both dTAFII16 and
dTAFII24 are found to be located at a large number of loci
(Fig. 5 and data not shown). Antibody
stainings revealed that both dTAFII16 and
dTAFII24 are associated with a unique subset of loci. As
shown by the localization of the binding sites of the two
dTAFIIs on the distal region of the polytene X
chromosome in wild-type strains, there are (i) loci which are stained
by both anti-dTAFII16 and anti-dTAFII24
antibodies (i.e., puff sites 3A and 3B) and (ii) loci which are
recognized only by either the anti-dTAFII16 (i.e., puff
sites 1D, 2B, and 3C) or anti-dTAFII24 (i.e., puff sites
1B, 1C, 2C, and 2D) antibodies (Fig. 5 and data not shown). These
observations further suggest that these two novel dTAFIIs
have not identical but overlapping functions and that functionally
different TAFII-containing complexes exist in
Drosophila.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 5.
Localization of dTAFII16 and
dTAFII24 proteins on the distal region of Drosophila
X chromosome. Immunostaining of polytene X chromosome
from wild-type larvae (Oregon R) was done with antibodies raised
against dTAFII16 (upper panel) and dTAFII24
(lower panel) and Cy3-conjugated secondary antibodies. The labeled
regions of chromosome X are indicated under both panels.
|
|
dTAFII16 and dTAFII24 are differentially
expressed during Drosophila embryogenesis.
Northern
blot analysis of poly(A)+ RNA extracted from embryonic
stages using either cDNA probes specific for each
dTAFII gene or a genomic fragment encompassing
both dTAFII genes showed that dTAFII16 produces a 0.95-kb poly(A)+
RNA transcript whereas dTAFII24 produces a
0.75-kb poly(A)+ RNA transcript (data not shown) and that
both classes of transcripts are produced during embryogenesis. We
investigated the spatiotemporal expression of both
dTAFII genes by either in situ hybridization of
whole-mount embryos using digoxigenin-labeled antisense RNA probes (and
sense RNA probes as controls) or immunocytochemistry using purified
antibodies raised against dTAFII16 and dTAFII24 proteins. For both dTAFII genes, the
developmental profile of protein expression follows that of RNA
expression (Fig. 6 and data not shown).
We found that at all embryonic stages examined, the level of RNA and
protein expression of dTAFII24 is constantly higher than that of dTAFII16, and we also
observed that maternally derived dTAFII24 and
dTAFII16 gene products (Fig. 6A to F) are present when the embryos undergo rapid nuclear divisions during the
syncytial preblastoderm stage. Similarly, ubiquitous distribution of
dTAFII16 and dTAFII24
transcripts was detected during early germ band elongation with
significantly higher levels of dTAFII24 RNA than
of dTAFII16 (compare Fig. 6G and H). The
differences in the expression patterns of dTAFII
genes appear at the end of germ band elongation, when different
embryonic tissue primordia are specified. At stage 9, the
dTAFII16 protein is preferentially synthesized in the
mesodermal layer and in the midgut primordia (Fig. 6I) while the
highest dTAFII24 level is detected within the ectoderm, the
ventral chord, and the anterior foregut primordium (Fig. 6J). The mesoderm-specific expression of dTAFII16
persists in later stages of development and at its highest level was
detected in midgut, hindgut (Fig. 6K), and differentiating somatic
muscle fibers (Fig. 7C). At the same time
dTAFII24 is preferentially expressed in the foregut (Fig.
6L and 7D), the proventriculus (Fig. 7D), and the central nervous
system (Fig. 6L and N and 7D). In addition, both genes are coexpressed
in the lateral epidermis (Fig. 6M and N) and the anal plate (Fig. 6K
and L). The finding that the dTAFII16 and
dTAFII24 genes display different levels of
transcription and tissue specificities during embryogenesis suggests
that their transcription is regulated by separate regulatory elements
and may thus have different functions.

View larger version (63K):
[in this window]
[in a new window]
|
FIG. 6.
Expression of dTAFII16 and
dTAFII24 during embryonic development.
Whole-mount embryos were hybridized with
dTAFII16 (A, C, G, and M) and
dTAFII24 (B, D, H, and N) antisense
single-stranded RNA probes labeled by incorporation of
dioxigenin-11-dUTP, as well as with dTAFII16 (O)
and dTAFII24 (P) sense probe. The
dTAFII16 (E, I, and K) and dTAFII24 (F, J, and
L) proteins were detected with purified PAbs and visualized using the
ABC Elite horse radish peroxidase detection kit (Vector Laboratories).
All embryos are oriented to the left and viewed laterally unless
otherwise indicated. (A and B) Evenly distributed dTAFII16
and dTAFII24 transcripts in early cleavage stage embryos,
~45 to 70 min after egg deposition. (C to F) Blastoderm embryos,
~120 to 130 min after egg deposition. Arrowheads indicate an
accumulation of dTAFII RNA (D) and proteins (E and F) close
the surface. (G and H) During germ band extension, ~260 to 320 min
after egg deposition, both dTAFII transcripts are seen in
the neuroectodermal and the mesodermal layers of the head and the trunk
(arrowheads). (I and J) Differential expression of dTAFII
proteins in embryos at the end of germ band extension, 190 to 220 min
after egg deposition. The dTAFII16 protein (I) was highly
expressed in the trunk mesoderm (tm) and the anterior (amg) and the
posterior midgut (pmg) primordia. In contrast, the highest expression
of dTAFII24 (J) appeared in the anterior foregut (afg) and
the ectodermal cells (ect) and in anlagen of the ventral cord (vca). (K
and L) Differential accumulation of dTAFII16 and
dTAFII24 proteins after germ band retraction. High levels
of dTAFII16 (K) was detected in the visceral musculature of
the midgut (amg and pmg) and the hindgut (hg) while
dTAFII24 (L) was preferentially expressed in the anterior
foregut (afg) and in the central nervous system (br and vc). Both
proteins are coexpressed in the anal plate (ap). (M, N, O, and P)
Dorsal (M, O, and P) and lateral (N) views of embryos at the time of
completion of germ band retraction, ~620 to 750 min after egg
deposition. Arrows in panels M and N show high transcript levels in the
lateral epidermis (ect) and in the brain (br).
|
|

View larger version (119K):
[in this window]
[in a new window]
|
FIG. 7.
Intracellular distribution of dTAFII16 and
dTAFII24 in Drosophila embryos. Confocal
scanning micrographs showing localization of dTAFIIs
labeled with purified anti-dTAFII16 (A and C) or
dTAFII24 (B and D) rabbit antibodies and secondary
anti-rabbit-Cy3 antibody (green) and of DNA labeled with propidium
iodide (red). (A) In the early preblastoderm embryos,
dTAFII16 is predominantly distributed in the cytoplasm. (B)
During germ band extension, a significant amount of
dTAFII24 is accumulated in the cytoplasm of ectodermal
cells. Both dTAFII proteins are also detected in the
periphery of nuclei (yellow; arrowheads in insets in A and B). (C) In
late-stage embryos, dTAFII16 localizes to the cytoplasm of
ectodermal cells (ect) and syncytial muscle fibers (sm) with nuclear
staining of the protein at the internal rim of the myocyte nuclei
(yellow; an example is indicated by an arrowhead). A scattered nuclear
dTAFII16 staining (yellow) appears also in the neural cells
of the ventral chord (vc). (D) After germ band retraction
dTAFII24 is essentially expressed in the ectoderm (ect) and
central nervous system (c) as well as in the foregut (fg) and
proventriculus (pv) primordium and moderately expressed in the salivary
gland (sg). In these tissues the dTAFII24 protein localizes
to the cytoplasm (green) and to the periphery of the nuclei (yellow).
|
|
To monitor the intracellular distribution of the
dTAFII24 and
dTAFII16
proteins, we used confocal microscopy (Fig.
7). Confocal
scans were
performed on whole-mount preparations of wild-type
embryos
double-stained with propidium iodide to visualize DNA
(red) and
fluorescent antibodies to visualize the dTAF
II proteins
(green). From early preblastoderm stages (Fig.
7A) up to germ
band
elongation (Fig.
7B), we found that both proteins were essentially
distributed throughout the cytoplasm with a higher concentration
around
the nuclei and were also detected at the periphery of the
nuclei (Fig.
7A and B). Similar intracellular distribution was
seen in different
embryonic tissues after germ band retraction.
For example, expression
of dTAF
II16 was predominant in the cytoplasm
of syncytial
muscle fibers (Fig.
7C) and detected at a lower level
in the periphery
of the myoblast nuclei (Fig.
7C). During late
embryogenesis, a weak
scattered nuclear staining of dTAF
II16 in
the ventral chord
(Fig.
7C) and a relatively stronger nuclear
expression of
dTAF
II24 in the brain (Fig.
7D) were also detected.
These
data, together with the observation that full-length
dTAF
II16
and dTAF
II24 proteins were detected in
both nuclear and cytoplasmic
extracts (Fig.
4A), indicate that
dTAF
II16 and dTAF
II24 proteins
display a
bicompartmental cellular distribution occurring both
in the cytoplasm
and also in the nuclei, where they seem to play
a role in the
transcriptional activity of the different TAF
II-containing
complexes.
 |
DISCUSSION |
Two homologue dTAFIIs appear by gene duplication to
have similar but not identical functions.
Initial studies
describing TFIID complexes from various species suggested that their
complexity may be higher in yeast and vertebrates than in
Drosophila. The recent progress made in the sequencing of
the Drosophila genome prompted us to look more carefully for
TAFII homologues. Through this analysis we discovered that Drosophila contains not one but two hTAFII30
homologues. In this study we have demonstrated that these two newly
identified dTAFII genes,
dTAFII16 and dTAFII24,
are transcribed and expressed throughout embryonic development.
Extensive searches in different databases for homologue sequences
revealed that to date,
Drosophila is the only organism known
to have two different TAF
II30 type factors (Fig.
3). In the
genomes
of
S. cerevisiae and
C. elegans, for
which the entire genome sequence
has been recently completed, only one
TAF
II30 homologue has been
found for each
(scTAF
II25 and ceTAF
II30 [Fig.
3]). The
occurrence
of two
TAFII30-related genes in the
Drosophila genome indicates
that they have arisen through a
relatively complex mechanism of
duplication, resulting in an inverted
orientation of the duplicate
genes with partial overlapping of their 5'
regions. As indicated
by the overlapping of the
dTAFII16 and
dTAFII24
gene structure,
the different positions of the intron located in each
of these
genes, and the divergence of the encoded proteins with
conserved
C-terminal moieties and divergent N-terminal moieties, we can
postulate that the duplication of the
dTAFII
genes occurred early
in arthropod ancestry. Further analysis of the
genomic organization
of these genes in other invertebrates species will
shed light
on the origin of their
duplication.
The organization of both genes is relatively unusual, with overlapping
of their putative promoter and 5' regions. In particular,
the promoter
region of the
dTAFII16 gene is found on the
opposite
strand within the
dTAFII24 coding
sequence, while the promoter
region of
dTAFII24
is located within the 5' untranslated region
of the second exon of
dTAFII16 (Fig.
1). Moreover, the putative
promoter regions show no or very little homology, suggesting different
mechanisms of regulation for each gene. Interestingly, the overlap
in
the 5' regions of both transcripts, which covers at least 128
nucleotides, does not prevent either the transcription of the
dTAFII16 and
dTAFII24
genes or the translation of their transcripts
into
proteins.
Surprisingly, the full-length dTAF
II16 and
dTAF
II24 proteins are not more similar to each other (48%
identity) than they are
to hTAF
II30 (54% identity between
dTAF
II16 and hTAF
II30 and 48%
identity between
dTAF
II24 and hTAF
II30). Furthermore,
dTAF
II16
displays a higher sequence similarity to the other
members of
the TAF
II30 family than dTAF
II24.
This sequence divergence suggests
that dTAF
II16 and
dTAF
II24 have different functions and that their
functions
have been subject to different evolutionary constraints.
While the
dTAF
II16 function may be similar in yeasts and humans,
dTAF
II24 may be important for a function(s) that tolerates
more
diversity.
In the classical model for the evolution of duplicate genes, one member
of the duplicated pair usually degenerates within
a few million years
by accumulating deleterious mutations, while
the other duplicate
retains the original function. This model
further predicts that on rare
occasions, one duplicate may acquire
a new adaptive function, resulting
in the preservation of both
members of the pair, one having the new
function and the other
retaining the old (references
12,
29,
31, and
32 and references
therein).
However, empirical data suggest that a much greater
proportion of gene
duplication is preserved than is predicted
by the classical model.
Alternatively, complementary degenerative
mutations in different
regulatory elements of duplicated genes
can facilitate the preservation
of both duplicates, thereby increasing
long-term opportunities for the
evolution of new gene functions
(
11). For a newly duplicated
paralog, survival depends on the
outcome of the race between entropic
decay and chance acquisition
of an advantageous regulatory mutation
(
37). Duplicated genes
persist only if mutations create new
and essential protein functions,
an event that is predicted to occur
rarely (
28). Our analysis
of
dTAFII16
and
dTAFII24 gene expression and our studies on
the
distribution of both dTAF
IIs in different multiprotein
complexes
support a mechanism of evolution involving
subfunctionalization
rather than the acquisition of a totally novel
function by one
of the dTAF
IIs. In particular, we have
found that both newly identified
dTAFII genes
exhibit similar expression during early embryogenesis
and a more
restricted pattern of expression during late embryogenesis
that is
nearly complementary. At this stage, the dTAF
II16 protein
is predominantly found in muscle cells whereas the dTAF
II24
protein
is more strongly expressed in the foregut and
midgut.
Different dTAFII16- and dTAFII24-containing
multiprotein complexes with distinct functions.
When
dTAFII16 and dTAFII24 are expressed
simultaneously in cells, like in 0- to 6-h embryos, both proteins were
found to be associated with TBP and a number of other bona fide
dTAFIIs, demonstrating that they are both present in TFIID
complexes. Since IP using an anti-dTAFII16 antibody
coimmunoprecipitates dTAFII24 and vice versa, these results
suggest that both dTAFIIs can be present in the same dTFIID
complex at the same time. Alternatively, as TFIID complexes have been
shown to dimerize when not bound to DNA (41), it is also
conceivable that in a given dTFIID the presence of dTAFII16
and dTAFII24 is mutually exclusive but they can be found in
the coimmunoprecipitations because a dTAFII16-containing TFIID could dimerize with a dTAFII24-containing TFIID.
Moreover, since both hTAFII30 and yTAFII25 were
shown to bind to themselves (17, 21), it is possible that
dTAFII16 and dTAFII24 behave similarly and thus
may participate in the dimerization of different dTFIIDs. During
development there are cells where only one of the two
dTAFIIs is expressed; therefore, the presence of the two dTAFIIs in different complexes is more likely.
Interestingly, our studies showed that dTAF
II24, but not
dTAF
II16, can be recovered in association with the dGCN5
HAT, suggesting
that dTAF
II24 has functional homology with
hTAF
II30 and yTAF
II25.
This result suggests
that a
Drosophila HAT complex exists that
may be equivalent
to the yeast SAGA or human TFTC, hPCAF/GCN5,
and hSTAGA complexes.
Moreover, the preferential association of
dTAF
II24 with the
GCN5 HAT complex further suggests that each
dTAF
II protein
carries out a defined function, with dTAF
II24 being
present
in both TFIID and
Drosophila TAF
II-GCN5
complexes whereas
dTAF
II16 is only a component of dTFIID.
The occurrence of distinct
dTAF
II16- and
dTAF
II24-containing multiprotein complexes in
Drosophila cells suggests that in
Drosophila,
similar to mammalian cells,
distinct functionally different
TAF
II-containing complexes exist
(
2,
5).
Alternatively, it is possible that the dTAF
II16
protein is
incorporated into only a very small number of dTAF
II-GCN5
complexes, which would remain undetectable under the conditions
used in
our studies. The distinct dTAF
II16- and
dTAF
II24-containing
complexes may have different affinities
for the chromatin, since
under less stringent conditions only the
dTAF
II24-containing complexes
could be recovered from
nuclei (Fig.
4A), further suggesting differential
roles for the
dTAF
II16- and dTAF
II24-containing
complexes. Moreover,
the observation that dTAF
II16
and dTAF
II24 are not always associated
with the same
transcriptionally active loci on polytene chromosomes
indicates that
the different dTAF
II16- and dTAF
II24-containing
complexes have distinct functions in gene
regulation.
The finding that the two dTAF
IIs have different
spatiotemporal expression levels, or eventually are not expressed at
all,
during embryogenesis suggests that (i) the composition of the
different TFIID and TAF
II-GCN5 complexes may change during
development,
(ii) the functions of these complexes may vary according
to the
promoter to which they become recruited, (iii) there may be gene
regulatory pathways which require either dTAF
II16 or
dTAF
II24,
and (iv) there may be cells which can function
without dTAF
II16
and dTAF
II24. These
observations are in good agreement with our
recent results showing that
in murine F9 cells TAF
II30 is required
for cell cycle
progression and parietal endodermal differentiation,
but not for
primitive endodermal differentiation (
27). Thus,
in metazoan
organisms TAF
IIs belonging to the TAF
II30
family may
be dispensable, but they are required for cells undergoing
either
rapid cell division or specific developmental differentiation
programs. Moreover, the observation that in several different
cell
types dTAF
IIs can be found in the cytoplasm raises new
questions
about the role of TAF
IIs in other functions than
those strictly
restricted to the nucleus. In agreement with our
finding, a fission
yeast TAF
II has recently been found to
participate in nucleocytoplasmic
transport of mRNAs (
36).
Further genetic and biochemical studies
will now be required in order
to analyze the functions of these
two newly identified
dTAF
IIs, to help further our understanding
of the
functional differences between dTAF
II16 and
dTAF
II24 during
the regulation of polymerase II
transcription, and to analyze
their potential new functions in the
context of an intact
organism.
 |
ACKNOWLEDGMENTS |
We are grateful to E. Scheer and R. Schmitt for excellent
technical assistance, to G. Duval for generating the
anti-dTAFII16 and anti-dTAFII24 PAbs, to Y. Nakatani and R. Tjian for antibodies, to P. B. Becker and K. P. Nightingale for Drosophila extracts, and to F. Müller and B. Bell for critically reading the manuscript. We also
thank P. Eberling for peptide synthesis, the cell culture group for
providing Schneider cells, F. Ruffenach for oligonucleotide synthesis,
and R. Buchert and J. M. Lafontaine for preparing the figures.
S.G. was supported by a fellowship from the Centre National de la
Recherche Scientifique (CNRS), S.G. and E.N. were supported by a grant
from the University of Oslo, Center of Medical Studies, Moscow, Russia,
and D.B.K. was supported by a Marie Curie fellowship from the European
Community. This work was supported by funds from the Institut National
de la Santé et de la Recherche Médicale, the CNRS, the
Hôpital Universitaire de Strasbourg, the Association pour la
Recherche sur le Cancer, the Fondation pour la Recherche Médicale, the Ligue Nationale contre le Cancer, the Human
Frontier Science Program, and the Commission of the European Union
(contracts CII*-CT92-0109, BMH1-94-1572, and BIO4-CT95-0202), the Swiss
Cancer League, and the International Office of the Bundesministerium für Bildung, Forschung und Technologie (contract INI-316).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut de
Génétique et de Biologie Moléculaire et Cellulaire,
CNRS/INSERM/ULP, BP 163, F67404 Illkirch Cedex, CU de Strasbourg,
France. Phone: 33 388 65 34 44. Fax: 33 388 65 32 01. E-mail:
laszlo{at}igbmc.u-strasbg.fr.
 |
REFERENCES |
| 1.
|
Becker, P. B., and C. Wu.
1992.
Cell-free system for assembly of transcriptionally repressed chromatin from Drosophila embryos.
Mol. Cell. Biol.
12:2241-2249[Abstract/Free Full Text].
|
| 2.
|
Bell, B., and L. Tora.
1999.
Regulation of gene expression by multiple forms of TFIID and other novel TAFII-containing complexes.
Exp. Cell Res.
246:11-19[CrossRef][Medline].
|
| 3.
|
Bertolotti, A.,
Y. Lutz,
D. J. Heard,
P. Chambon, and L. Tora.
1996.
hTAFII68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II.
EMBO J.
15:5022-5031[Medline].
|
| 4.
|
Bertolotti, A.,
T. Melot,
J. Acker,
M. Vigneron,
O. Delattre, and L. Tora.
1998.
EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.
Mol. Cell. Biol.
18:1489-1497[Abstract/Free Full Text].
|
| 5.
|
Brand, M.,
K. Yamamoto,
A. Staub, and L. Tora.
1999.
Identification of TATA-binding protein-free TAFII-containing complex subunits suggests a role in nucleosome acetylation and signal transduction.
J. Biol. Chem.
274:18285-18289[Abstract/Free Full Text].
|
| 6.
|
Brou, C.,
S. Chaudhary,
I. Davidson,
Y. Lutz,
J. Wu,
J. M. Egly,
L. Tora, and P. Chambon.
1993.
Distinct TFIID complexes mediate the effect of different transcriptional activators.
EMBO J.
12:489-499[Medline].
|
| 7.
|
Candau, R.,
J. X. Zhou,
C. D. Allis, and S. L. Berger.
1997.
Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo.
EMBO J.
16:555-565[CrossRef][Medline].
|
| 8.
|
Chen, J. L.,
L. D. Attardi,
C. P. Verrijzer,
K. Yokomori, and R. Tjian.
1994.
Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators.
Cell
79:93-105[CrossRef][Medline].
|
| 9.
|
Dikstein, R.,
S. Zhou, and R. Tjian.
1996.
Human TAFII105 is a cell type-specific TFIID subunit related to hTAFII130.
Cell
87:137-146[CrossRef][Medline].
|
| 10.
|
Dynlacht, B. D.,
R. O. Weinzierl,
A. Admon, and R. Tjian.
1993.
The dTAFII80 subunit of Drosophila TFIID contains beta-transducin repeats.
Nature
363:176-179[CrossRef][Medline].
|
| 11.
|
Force, A.,
M. Lynch,
F. B. Pickett,
A. Amores,
Y. L. Yan, and J. Postlethwait.
1999.
Preservation of duplicate genes by complementary, degenerative mutations.
Genetics
151:1531-1545[Abstract/Free Full Text].
|
| 12.
|
Ganfornina, M. D., and D. Sanchez.
1999.
Generation of evolutionary novelty by functional shift.
Bioessays
21:432-439[CrossRef][Medline].
|
| 13.
|
Grant, P. A.,
D. Schieltz,
M. G. Pray-Grant,
D. J. Steger,
J. C. Reese,
J. R. Yates, and J. L. Workman.
1998.
A subset of TAF(II)s are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation.
Cell
94:45-53[CrossRef][Medline].
|
| 14.
|
Gregory, P. D.,
A. Schmid,
M. Zavari,
L. Lui,
S. L. Berger, and W. Horz.
1998.
Absence of Gcn5 HAT activity defines a novel state in the opening of chromatin at the PHO5 promoter in yeast.
Mol. Cell
1:495-505[CrossRef][Medline].
|
| 15.
|
Hansen, S. K., and R. Tjian.
1995.
TAFs and TFIIA mediate differential utilization of the tandem Adh promoters.
Cell
82:565-575[CrossRef][Medline].
|
| 16.
|
Hartenstein, K.,
P. Sinha,
A. Mishra,
H. Schenkel,
I. Torok, and B. M. Mechler.
1997.
The congested-like tracheae gene of Drosophila melanogaster encodes a member of the mitochondrial carrier family required for gas-filling of the tracheal system and expansion of the wings after eclosion.
Genetics
147:1755-1768[Abstract].
|
| 17.
|
Jacq, X.,
C. Brou,
Y. Lutz,
I. Davidson,
P. Chambon, and L. Tora.
1994.
Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor.
Cell
79:107-117[CrossRef][Medline].
|
| 18.
|
Jeanmougin, F.,
J. D. Thompson,
M. Gouy,
D. G. Higgins, and T. J. Gibson.
1998.
Multiple sequence alignment with Clustal X.
Trends Biochem. Sci.
23:403-405[CrossRef][Medline].
|
| 19.
|
Kamakaka, R. T.,
C. M. Tyree, and J. T. Kadonaga.
1991.
Accurate and efficient RNA polymerase II transcription with a soluble nuclear fraction derived from Drosophila embryos.
Proc. Natl. Acad. Sci. USA
88:1024-1028[Abstract/Free Full Text].
|
| 20.
|
Kazantsev, A.,
D. Mu,
A. F. Nichols,
X. Zhao,
S. Linn, and A. Sancar.
1996.
Functional complementation of xeroderma pigmentosum complementation group E by replication protein A in an in vitro system.
Proc. Natl. Acad. Sci. USA
93:5014-5018[Abstract/Free Full Text].
|
| 21.
|
Klebanow, E. R.,
D. Poon,
S. Zhou, and P. A. Weil.
1996.
Isolation and characterization of TAF25, an essential yeast gene that encodes an RNA polymerase II-specific TATA-binding protein-associated factor.
J. Biol. Chem.
271:13706-13715[Abstract/Free Full Text].
|
| 22.
|
Kokubo, T.,
D.-W. Gong,
J. C. Wootton,
M. Horikoshi,
R. G. Roeder, and Y. Nakatani.
1994.
Molecular cloning of Drosophila TFIID subunits.
Nature
367:484-487[CrossRef][Medline].
|
| 23.
|
Kokubo, T.,
D. W. Gong,
S. Yamashita,
M. Horikoshi,
R. G. Roeder, and Y. Nakatani.
1993.
Drosophila 230-kD TFIID subunit, a functional homolog of the human cell cycle gene product, negatively regulates DNA binding of the TATA box-binding subunit of TFIID.
Genes Dev.
7:1033-1046[Abstract/Free Full Text].
|
| 24.
|
Kuo, M. H., and C. D. Allis.
1998.
Roles of histone acetyltransferases and deacetylases in gene regulation.
Bioessays
20:615-626[CrossRef][Medline].
|
| 25.
|
Lee, T. I., and R. A. Young.
1998.
Regulation of gene expression by TBP-associated proteins.
Genes Dev.
12:1398-1408[Free Full Text].
|
| 26.
|
Martinez, E.,
T. K. Kundu,
J. Fu, and R. G. Roeder.
1998.
A human SPT3-TAFII31-GCN5-L acetylase complex distinct from transcription factor IID.
J. Biol. Chem.
273:23781-23785[Abstract/Free Full Text].
|
| 27.
|
Metzger, D.,
E. Scheer,
A. Soldatov, and L. Tora.
1999.
Mammalian TAF(II)30 is required for cell cycle progression and specific cellular differentiation programmes.
EMBO J.
18:4823-4834[CrossRef][Medline].
|
| 28.
|
Nadeau, J. H., and D. Sankoff.
1997.
Comparable rates of gene loss and functional divergence after genome duplications early in vertebrate evolution.
Genetics
147:1259-1266[Abstract].
|
| 29.
|
Nei, M., and A. K. Roychoudhury.
1973.
Probability of fixation and mean fixation time of an overdominant mutation.
Genetics
74:371-380[Abstract/Free Full Text].
|
| 30.
|
Ogryzko, V. V.,
T. Kotani,
X. Zhang,
R. L. Schlitz,
T. Howard,
X. J. Yang,
B. H. Howard,
J. Qin, and Y. Nakatani.
1998.
Histone-like TAFs within the PCAF histone acetylase complex.
Cell
94:35-44[CrossRef][Medline].
|
| 31.
|
Ohno, S.
1993.
Patterns in genome evolution.
Curr. Opin. Genet. Dev.
3:911-914[CrossRef][Medline].
|
| 32.
|
Ohno, S.,
U. Wolf, and N. B. Atkin.
1968.
Evolution from fish to mammals by gene duplication.
Hereditas
59:169-187[Medline].
|
| 33.
|
Platero, J. S.,
E. J. Sharp,
P. N. Adler, and J. C. Eissenberg.
1996.
In vivo assay for protein-protein interactions using Drosophila chromosomes.
Chromosoma
104:393-404[Medline].
|
| 34.
|
Sandaltzopoulos, R., and P. B. Becker.
1995.
Analysis of protein-DNA interaction by solid-phase footprinting.
Methods Mol. Cell Biol.
5:176-181.
|
| 35.
|
Sanders, S. L.,
E. R. Klebanow, and P. A. Weil.
1999.
TAF25p, a non-histone-like subunit of TFIID and SAGA complexes, is essential for total mRNA gene transcription in vivo.
J. Biol. Chem.
274:18847-18850[Abstract/Free Full Text].
|
| 36.
|
Shibuya, T.,
S. Tsuneyoshi,
A. K. Azad,
S. Urushiyama,
Y. Ohshima, and T. Tani.
1999.
Characterization of the ptr6(+) gene in fission yeast. A possible involvement of a transcriptional coactivator TAFII in nucleocytoplasmic transport of mRNA.
Genetics
152:869-880[Abstract/Free Full Text].
|
| 37.
|
Sidow, A.
1996.
Gen(om)e duplications in the evolution of early vertebrates.
Curr. Opin. Genet. Dev.
6:715-722[CrossRef][Medline].
|
| 38.
|
Smith, E. R.,
J. M. Belote,
R. L. Schiltz,
X. J. Yang,
P. A. Moore,
S. L. Berger,
Y. Nakatani, and C. D. Allis.
1998.
Cloning of Drosophila GCN5: conserved features among metazoan GCN5 family members.
Nucleic Acids Res.
26:2948-2954[Abstract/Free Full Text].
|
| 39.
|
Soldatov, A.,
E. Nabirochkina,
S. Georgieva,
T. Belenkaja, and P. Georgiev.
1999.
TAFII40 protein is encoded by the e(y)1 gene: biological consequences of mutations.
Mol. Cell. Biol.
19:3769-3778[Abstract/Free Full Text].
|
| 40.
|
Struhl, K., and Z. Moqtaderi.
1998.
The TAFs in the HAT.
Cell
94:1-4[CrossRef][Medline].
|
| 41.
|
Taggart, A. K., and B. F. Pugh.
1996.
Dimerization of TFIID when not bound to DNA.
Science
272:1331-1333[Abstract].
|
| 42.
|
Tansey, W. P., and W. Herr.
1997.
TAFs: guilt by association?
Cell
88:729-732[CrossRef][Medline].
|
| 43.
|
Tjian, R., and T. Maniatis.
1994.
Transcriptional activation: a complex puzzle with few easy pieces.
Cell
77:5-8[CrossRef][Medline].
|
| 44.
|
Torok, I.,
D. Strand,
R. Schmitt,
G. Tick,
T. Torok,
I. Kiss, and B. M. Mechler.
1995.
The overgrown hematopoietic organs-31 tumor suppressor gene of Drosophila encodes an Importin-like protein accumulating in the nucleus at the onset of mitosis.
J. Cell Biol.
129:1473-1489[Abstract/Free Full Text].
|
| 45.
|
Wieczorek, E.,
M. Brand,
X. Jacq, and L. Tora.
1998.
Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II.
Nature
393:187-191[CrossRef][Medline].
|
| 46.
|
Workman, J. L., and R. E. Kingston.
1998.
Alteration of nucleosome structure as a mechanism of transcriptional regulation.
Annu. Rev. Biochem.
67:545-579[CrossRef][Medline].
|
| 47.
|
Yokomori, K.,
J. L. Chen,
A. Admon,
S. Zhou, and R. Tjian.
1993.
Molecular cloning and characterization of dTAFII30 alpha and dTAFII30 beta: two small subunits of Drosophila TFIID.
Genes Dev.
7:2587-2597[Abstract/Free Full Text].
|
| 48.
|
Zhang, W.,
J. R. Bone,
D. G. Edmondson,
B. M. Turner, and S. Y. Roth.
1998.
Essential and redundant functions of histone acetylation revealed by mutation of target lysines and loss of the Gcn5p acetyltransferase.
EMBO J.
17:3155-3167[CrossRef][Medline].
|
Molecular and Cellular Biology, March 2000, p. 1639-1648, Vol. 20, No. 5
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vorobyeva, N. E., Soshnikova, N. V., Nikolenko, J. V., Kuzmina, J. L., Nabirochkina, E. N., Georgieva, S. G., Shidlovskii, Y. V.
(2009). Transcription coactivator SAYP combines chromatin remodeler Brahma and transcription initiation factor TFIID into a single supercomplex. Proc. Natl. Acad. Sci. USA
106: 11049-11054
[Abstract]
[Full Text]
-
Prince, F., Katsuyama, T., Oshima, Y., Plaza, S., Resendez-Perez, D., Berry, M., Kurata, S., Gehring, W. J.
(2008). The YPWM motif links Antennapedia to the basal transcriptional machinery. Development
135: 1669-1679
[Abstract]
[Full Text]
-
Tamada, Y., Nakamori, K., Nakatani, H., Matsuda, K., Hata, S., Furumoto, T., Izui, K.
(2007). Temporary Expression of the TAF10 Gene and its Requirement for Normal Development of Arabidopsis thaliana. Plant Cell Physiol
48: 134-146
[Abstract]
[Full Text]
-
Ciurciu, A., Komonyi, O., Pankotai, T., Boros, I. M.
(2006). The Drosophila Histone Acetyltransferase Gcn5 and Transcriptional Adaptor Ada2a Are Involved in Nucleosomal Histone H4 Acetylation. Mol. Cell. Biol.
26: 9413-9423
[Abstract]
[Full Text]
-
Kopytova, D. V., Krasnov, A. N., Kopantceva, M. R., Nabirochkina, E. N., Nikolenko, J. V., Maksimenko, O., Kurshakova, M. M., Lebedeva, L. A., Yerokhin, M. M., Simonova, O. B., Korochkin, L. I., Tora, L., Georgiev, P. G., Georgieva, S. G.
(2006). Two Isoforms of Drosophila TRF2 Are Involved in Embryonic Development, Premeiotic Chromatin Condensation, and Proper Differentiation of Germ Cells of Both Sexes.. Mol. Cell. Biol.
26: 7492-7505
[Abstract]
[Full Text]
-
Gao, X., Ren, F., Lu, Y.-T.
(2006). The Arabidopsis Mutant stg1 Identifies a Function for TBP-Associated Factor 10 in Plant Osmotic Stress Adaptation. Plant Cell Physiol
47: 1285-1294
[Abstract]
[Full Text]
-
Lebedeva, L. A., Nabirochkina, E. N., Kurshakova, M. M., Robert, F., Krasnov, A. N., Evgen'ev, M. B., Kadonaga, J. T., Georgieva, S. G., Tora, L.
(2005). Occupancy of the Drosophila hsp70 promoter by a subset of basal transcription factors diminishes upon transcriptional activation. Proc. Natl. Acad. Sci. USA
102: 18087-18092
[Abstract]
[Full Text]
-
Krasnov, A. N., Kurshakova, M. M., Ramensky, V. E., Mardanov, P. V., Nabirochkina, E. N., Georgieva, S. G.
(2005). A retrocopy of a gene can functionally displace the source gene in evolution. Nucleic Acids Res
33: 6654-6661
[Abstract]
[Full Text]
-
Pankotai, T., Komonyi, O., Bodai, L., Ujfaludi, Z., Muratoglu, S., Ciurciu, A., Tora, L., Szabad, J., Boros, I.
(2005). The Homologous Drosophila Transcriptional Adaptors ADA2a and ADA2b Are both Required for Normal Development but Have Different Functions. Mol. Cell. Biol.
25: 8215-8227
[Abstract]
[Full Text]
-
Frontini, M., Soutoglou, E., Argentini, M., Bole-Feysot, C., Jost, B., Scheer, E., Tora, L.
(2005). TAF9b (Formerly TAF9L) Is a Bona Fide TAF That Has Unique and Overlapping Roles with TAF9. Mol. Cell. Biol.
25: 4638-4649
[Abstract]
[Full Text]
-
Soutoglou, E., Demeny, M. A., Scheer, E., Fienga, G., Sassone-Corsi, P., Tora, L.
(2005). The Nuclear Import of TAF10 Is Regulated by One of Its Three Histone Fold Domain-Containing Interaction Partners. Mol. Cell. Biol.
25: 4092-4104
[Abstract]
[Full Text]
-
Furumoto, T., Tamada, Y., Izumida, A., Nakatani, H., Hata, S., Izui, K.
(2005). Abundant Expression in Vascular Tissue of Plant TAF10, an Orthologous Gene for TATA Box-binding Protein-associated Factor 10, in Flaveria trinervia and Abnormal Morphology of Arabidopsis thaliana Transformants on its Overexpression. Plant Cell Physiol
46: 108-117
[Abstract]
[Full Text]
-
Hiller, M., Chen, X., Pringle, M. J., Suchorolski, M., Sancak, Y., Viswanathan, S., Bolival, B., Lin, T.-Y., Marino, S., Fuller, M. T.
(2004). Testis-specific TAF homologs collaborate to control a tissue-specific transcription program. Development
131: 5297-5308
[Abstract]
[Full Text]
-
Muratoglu, S., Georgieva, S., Papai, G., Scheer, E., Enunlu, I., Komonyi, O., Cserpan, I., Lebedeva, L., Nabirochkina, E., Udvardy, A., Tora, L., Boros, I.
(2003). Two Different Drosophila ADA2 Homologues Are Present in Distinct GCN5 Histone Acetyltransferase-Containing Complexes. Mol. Cell. Biol.
23: 306-321
[Abstract]
[Full Text]
-
Kobayashi, A., Akasaka, K., Kawaichi, M., Kokubo, T.
(2002). Functional interaction between TATA and upstream CACGTG elements regulates the temporally specific expression of Otx mRNAs during early embryogenesis of the sea urchin, Hemicentrotus pulcherrimus. Nucleic Acids Res
30: 3034-3044
[Abstract]
[Full Text]
-
Kirchner, J., Sanders, S. L., Klebanow, E., Weil, P. A.
(2001). Molecular Genetic Dissection of TAF25, an Essential Yeast Gene Encoding a Subunit Shared by TFIID and SAGA Multiprotein Transcription Factors. Mol. Cell. Biol.
21: 6668-6680
[Abstract]
[Full Text]
-
Gangloff, Y.-G., Pointud, J.-C., Thuault, S., Carre, L., Romier, C., Muratoglu, S., Brand, M., Tora, L., Couderc, J.-L., Davidson, I.
(2001). The TFIID Components Human TAFII140 and Drosophila BIP2 (TAFII155) Are Novel Metazoan Homologues of Yeast TAFII47 Containing a Histone Fold and a PHD Finger. Mol. Cell. Biol.
21: 5109-5121
[Abstract]
[Full Text]
-
Georgieva, S., Nabirochkina, E., Dilworth, F. J., Eickhoff, H., Becker, P., Tora, L., Georgiev, P., Soldatov, A.
(2001). The Novel Transcription Factor e(y)2 Interacts with TAFII40 and Potentiates Transcription Activation on Chromatin Templates. Mol. Cell. Biol.
21: 5223-5231
[Abstract]
[Full Text]
-
Hiller, M. A., Lin, T.-Y., Wood, C., Fuller, M. T.
(2001). Developmental regulation of transcription by a tissue-specific TAF homolog. Genes Dev.
15: 1021-1030
[Abstract]
[Full Text]
-
Gangloff, Y.-G., Sanders, S. L., Romier, C., Kirschner, D., Weil, P. A., Tora, L., Davidson, I.
(2001). Histone Folds Mediate Selective Heterodimerization of Yeast TAFII25 with TFIID Components yTAFII47 and yTAFII65 and with SAGA Component ySPT7. Mol. Cell. Biol.
21: 1841-1853
[Abstract]
[Full Text]
-
Hernández-Hernández, A., Ferrús, A.
(2001). Prodos Is a Conserved Transcriptional Regulator That Interacts with dTAFII16 in Drosophila melanogaster. Mol. Cell. Biol.
21: 614-623
[Abstract]
[Full Text]
-
Aoyagi, N., Wassarman, D. A.
(2000). Genes Encoding Drosophila melanogaster RNA Polymerase II General Transcription Factors: Diversity in Tfiia and Tfiid Components Contributes to Gene-Specific Transcriptional Regulation. JCB
150: 45-50
[Full Text]
-
Sterner, D. E., Berger, S. L.
(2000). Acetylation of Histones and Transcription-Related Factors. Microbiol. Mol. Biol. Rev.
64: 435-459
[Abstract]
[Full Text]
-
Sanders, S. L., Weil, P. A.
(2000). Identification of Two Novel TAF Subunits of the Yeast Saccharomyces cerevisiae TFIID Complex. J. Biol. Chem.
275: 13895-13900
[Abstract]
[Full Text]